{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T10:57:49Z","timestamp":1791629869354,"version":"4.3.4"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371215"],"award-info":[{"award-number":["81371215"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670786"],"award-info":[{"award-number":["81670786"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019166","name":"Department of Transportation of Zhejiang Province","doi-asserted-by":"publisher","award":["2021 C03094"],"award-info":[{"award-number":["2021 C03094"]}],"id":[{"id":"10.13039\/100019166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In recent years, more studies have observed that patients with Prader\u2013Willi syndrome have lower insulin levels and lower insulin resistance than body mass index-matched controls, which may suggest protected glucose metabolism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>The PubMed and Web of Science online databases were searched to identify relevant studies published in the English language using the terms \u201cPrader\u2013Willi syndrome\u201d with \u201cglucose\u201d, \u201cinsulin\u201d, \u201cdiabetes mellitus\u201d, \u201cfat\u201d, \u201cadipo*\u201d, \u201cghrelin\u201d, \u201coxytocin\u201d, \u201cirisin\u201d or \u201cautonomic nervous system\u201d.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The prevalence of impaired glucose intolerance, type 2 diabetes mellitus and some other obesity-associated complications in patients with Prader\u2013Willi syndrome tends to be lower when compared to that in general obesity, which is consistent with the hypothetically protected glucose metabolism. Factors including adipose tissue, adiponectin, ghrelin, oxytocin, irisin, growth hormone and the autonomic nervous system possibly modulate insulin sensitivity in patients with Prader\u2013Willi syndrome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Although lower insulin levels, lower IR and protected glucose metabolism are widely reported in PWS patients, the causes are still mysterious. Based on existing knowledge, we cannot determine which factor is of utmost importance and what are the underlying mechanisms, and further research is in urgent need.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02344-3","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T11:21:02Z","timestamp":1651922462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Do patients with Prader\u2013Willi syndrome have favorable glucose metabolism?"],"prefix":"10.1186","volume":"17","author":[{"given":"Yanjie","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangling","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mianling","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4667-3636","authenticated-orcid":false,"given":"Chaochun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,7]]},"reference":[{"key":"2344_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S2213-8587(21)00002-4","volume":"9","author":"M Tauber","year":"2021","unstructured":"Tauber M, Hoybye C. Endocrine disorders in Prader\u2013Willi syndrome: a model to understand and treat hypothalamic dysfunction. Lancet Diabetes Endocrinol. 2021;9:235\u201346.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2344_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11892-020-1284-5","volume":"20","author":"A Crino","year":"2020","unstructured":"Crino A, Grugni G. Update on diabetes mellitus and glucose metabolism alterations in Prader\u2013Willi syndrome. Curr Diab Rep. 2020;20(2):7.","journal-title":"Curr Diab Rep"},{"issue":"4","key":"2344_CR3","first-page":"269","volume":"21","author":"P Brambilla","year":"2011","unstructured":"Brambilla P, Crin\u00f2 A, Bedogni G, Bosio L, Cappa M, Corrias A, et al. Metabolic syndrome in children with Prader\u2013Willi syndrome: the effect of obesity. Nutr Metab Cardiovasc Dis. 2011;21(4):269\u201376.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"11","key":"2344_CR4","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.numecd.2012.11.006","volume":"23","author":"G Grugni","year":"2013","unstructured":"Grugni G, Crino A, Bedogni G, Cappa M, Sartorio A, Corrias A, et al. Metabolic syndrome in adult patients with Pradere\u2013Willi syndrome. Nutr Metab Cardiovasc Dis. 2013;23(11):1134\u201340.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"9","key":"2344_CR5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.numecd.2016.05.010","volume":"26","author":"D Fintini","year":"2016","unstructured":"Fintini D, Grugni G, Bocchini S, Brufani C, Di Candia S, Corrias A, et al. Disorders of glucose metabolism in Prader\u2013Willi syndrome: results of a multicenter Italian cohort study. Nutr Metab Cardiovasc Dis. 2016;26(9):842\u20137.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"2344_CR6","first-page":"239","volume":"59","author":"D L\u2019Allemand","year":"2003","unstructured":"L\u2019Allemand D, Eiholzer U, Schlumpf M, Torresani T, Girard J. Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader\u2013Willi syndrome. Horm Res. 2003;59(5):239\u201348.","journal-title":"Horm Res"},{"issue":"2","key":"2344_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1297\/cpe.20.33","volume":"20","author":"T Tsuchiya","year":"2011","unstructured":"Tsuchiya T, Oto Y, Ayabe T, Obata K, Murakami N, Nagai T. Characterization of diabetes mellitus in Japanese Prader\u2013Willi syndrome. Clin Pediatr Endocrinol. 2011;20(2):33\u20138.","journal-title":"Clin Pediatr Endocrinol"},{"issue":"Suppl 5","key":"2344_CR8","first-page":"1279","volume":"15","author":"MG Butler","year":"2002","unstructured":"Butler MG. Imprinting disorders: non-Mendelian mechanisms affecting growth. J Pediatr Endocrinol Metab. 2002;15(Suppl 5):1279\u201388.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"433","key":"2344_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1651-2227.1999.tb14418.x","volume":"88","author":"WB Zipf","year":"1999","unstructured":"Zipf WB. Glucose homeostasis in Prader\u2013Willi syndrome and potential implications of growth hormone therapy. Acta Paediatr Suppl. 1999;88(433):115\u20137.","journal-title":"Acta Paediatr Suppl"},{"issue":"3","key":"2344_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/ijpo.12052","volume":"11","author":"D Fintini","year":"2016","unstructured":"Fintini D, Inzaghi E, Colajacomo M, Bocchini S, Grugni G, Brufani C, et al. Non-alcoholic fatty liver disease (NAFLD) in children and adolescents with Prader\u2013Willi syndrome (PWS). Pediatr Obes. 2016;11(3):235\u20138.","journal-title":"Pediatr Obes"},{"issue":"7","key":"2344_CR11","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1515\/JPEM.2006.19.7.911","volume":"19","author":"AG Krochik","year":"2006","unstructured":"Krochik AG, Ozuna B, Torrado M, Chertkoff L, Mazza C. Characterization of alterations in carbohydrate metabolism in children with Prader\u2013Willi syndrome. J Pediatr Endocrinol Metab. 2006;19(7):911\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"12","key":"2344_CR12","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/ijo.2011.274","volume":"36","author":"AP Goldstone","year":"2012","unstructured":"Goldstone AP, Holland AJ, Butler JV, Whittington JE. Appetite hormones and the transition to hyperphagia in children with Prader\u2013Willi syndrome. Int J Obes. 2012;36(12):1564\u201370.","journal-title":"Int J Obes"},{"issue":"6","key":"2344_CR13","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1365-2265.2007.02991.x","volume":"67","author":"AM Haqq","year":"2007","unstructured":"Haqq AM, Muehlbauer M, Svetkey LP, Newgard CB, Purnell JQ, Grambow SC, et al. Altered distribution of adiponectin isoforms in children with Prader\u2013Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones. Clin Endocrinol. 2007;67(6):944\u201351.","journal-title":"Clin Endocrinol"},{"issue":"6","key":"2344_CR14","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/oby.21041","volume":"23","author":"L Purtell","year":"2015","unstructured":"Purtell L, Viardot A, Sze L, Loughnan G, Steinbeck K, Sainsbury A, et al. Postprandial metabolism in adults with Prader\u2013Willi syndrome. Obesity. 2015;23(6):1159\u201365.","journal-title":"Obesity"},{"issue":"10","key":"2344_CR15","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1210\/jc.2015-2503","volume":"100","author":"P Gumus Balikcioglu","year":"2015","unstructured":"Gumus Balikcioglu P, Balikcioglu M, Muehlbauer MJ, Purnell JQ, Broadhurst D, Freemark M, et al. Macronutrient regulation of ghrelin and peptide YY in pediatric obesity and Prader\u2013Willi syndrome. J Clin Endocrinol Metab. 2015;100(10):3822\u201331.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2344_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136864","volume":"10","author":"HJ Hirsch","year":"2015","unstructured":"Hirsch HJ, Gross I, Pollak Y, Eldar-Geva T, Gross-Tsur V. Irisin and the metabolic phenotype of adults with Prader\u2013Willi syndrome. PLoS ONE. 2015;10(9): e0136864.","journal-title":"PLoS ONE"},{"key":"2344_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13023-017-0702-5","volume":"12","author":"A Yang","year":"2017","unstructured":"Yang A, Kim J, Cho SY, Jin D-K. Prevalence and risk factors for type 2 diabetes mellitus with Prader\u2013Willi syndrome: a single center experience. Orphanet J Rare Dis. 2017;12:146.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2344_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000358570","volume":"7","author":"G Bedogni","year":"2014","unstructured":"Bedogni G, Grugni G, Nobili V, Agosti F, Saezza A, Sartorio A. Is non-alcoholic fatty liver disease less frequent among women with Prader\u2013Willi syndrome? Obes Facts. 2014;7(1):71\u20136.","journal-title":"Obes Facts"},{"issue":"1","key":"2344_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ajmg.a.35653","volume":"161A","author":"Y Tanaka","year":"2013","unstructured":"Tanaka Y, Abe Y, Oto Y, Itabashi H, Shiraishi M, Yoshino A, et al. Characterization of fat distribution in Prader\u2013Willi syndrome: relationships with adipocytokines and influence of growth hormone treatment. Am J Med Genet Part A. 2013;161A(1):27.","journal-title":"Am J Med Genet Part A"},{"issue":"8","key":"2344_CR20","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65(8):1038\u201348.","journal-title":"Metabolism"},{"issue":"5","key":"2344_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrendo.2014.29","volume":"10","author":"M Laakso","year":"2014","unstructured":"Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10(5):293\u2013302.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"2344_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.npep.2011.06.001","volume":"45","author":"L Purtell","year":"2011","unstructured":"Purtell L, Sze L, Loughnan G, Smith E, Herzog H, Sainsbury A, et al. In adults with Prader\u2013Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels. Neuropeptides. 2011;45(4):301\u20137.","journal-title":"Neuropeptides"},{"issue":"7","key":"2344_CR23","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1210\/jc.2009-2492","volume":"95","author":"A Viardot","year":"2010","unstructured":"Viardot A, Sze L, Purtell L, Sainsbury A, Loughnan G, Smith E, et al. Prader\u2013Willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance. J Clin Endocrinol Metab. 2010;95(7):3392\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2344_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0022-3476(99)70419-1","volume":"134","author":"U Eiholzer","year":"1999","unstructured":"Eiholzer U, Blum WF, Molinari L. Body fat determined by skinfold measurements is elevated despite underweight in infants with Prader\u2013Labhart\u2013Willi syndrome. J Pediatr. 1999;134(2):222\u20135.","journal-title":"J Pediatr"},{"issue":"3","key":"2344_CR25","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1210\/jc.2014-3127","volume":"100","author":"D Lacroix","year":"2015","unstructured":"Lacroix D, Moutel S, Coupaye M, Huvenne H, Faucher P, Pelloux V, et al. Metabolic and adipose tissue signatures in adults with Prader\u2013Willi syndrome: a model of extreme adiposity. J Clin Endocrinol Metab. 2015;100(3):850\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2344_CR26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1399-0004.2004.00392.x","volume":"67","author":"Z Talebizadeh","year":"2005","unstructured":"Talebizadeh Z, Butler MG. Insulin resistance and obesity-related factors in Prader\u2013Willi syndrome: comparison with obese subjects. Clin Genet. 2005;67(3):230\u20139.","journal-title":"Clin Genet"},{"issue":"7","key":"2344_CR27","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/ijo.2010.216","volume":"35","author":"V Primeau","year":"2011","unstructured":"Primeau V, Coderre L, Karelis AD, Brochu M, Lavoie M-E, Messier V, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond). 2011;35(7):971\u201381.","journal-title":"Int J Obes (Lond)"},{"issue":"9","key":"2344_CR28","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s40618-015-0266-y","volume":"38","author":"G Bedogni","year":"2015","unstructured":"Bedogni G, Grugni G, Tringali G, Marazzi N, Sartorio A. Does segmental body composition differ in women with Prader\u2013Willi syndrome compared to women with essential obesity? J Endocrinol Invest. 2015;38(9):957\u201361.","journal-title":"J Endocrinol Invest"},{"key":"2344_CR29","volume":"2013","author":"P Patel","year":"2013","unstructured":"Patel P, Abate N. Role of subcutaneous adipose tissue in the pathogenesis of insulin resistance. J Obes. 2013;2013: 489187.","journal-title":"J Obes"},{"issue":"9","key":"2344_CR30","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00125-002-0873-y","volume":"45","author":"KN Frayn","year":"2002","unstructured":"Frayn KN. Adipose tissue as a buffer for daily lipid flux. Diabetologia. 2002;45(9):1201\u201310.","journal-title":"Diabetologia"},{"issue":"9","key":"2344_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0060237","volume":"6","author":"S Virtue","year":"2008","unstructured":"Virtue S, Vidal-Puig A. It\u2019s not how fat you are, it\u2019s what you do with it that counts. PLoS Biol. 2008;6(9): e237.","journal-title":"PLoS Biol"},{"issue":"1","key":"2344_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.gene.2012.01.027","volume":"497","author":"JR Bush","year":"2012","unstructured":"Bush JR, Wevrick R. Loss of the Prader\u2013Willi obesity syndrome protein necdin promotes adipogenesis. Gene. 2012;497(1):45\u201351.","journal-title":"Gene"},{"issue":"9","key":"2344_CR33","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/ijo.2014.3","volume":"38","author":"T Cadoudal","year":"2014","unstructured":"Cadoudal T, Bul\u00e9on M, Sengen\u00e8s C, Diene G, Desneulin F, Molinas C, et al. Impairment of adipose tissue in Prader\u2013Willi syndrome rescued by growth hormone treatment. Int J Obes (Lond). 2014;38(9):1234\u201340.","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"2344_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030948","volume":"7","author":"K Fujiwara","year":"2012","unstructured":"Fujiwara K, Hasegawa K, Ohkumo T, Miyoshi H, Tseng Y-H, Yoshikawa K. Necdin controls proliferation of white adipocyte progenitor cells. PLoS ONE. 2012;7(1): e30948.","journal-title":"PLoS ONE"},{"issue":"1","key":"2344_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/00041433-199802000-00008","volume":"9","author":"DG Carey","year":"1998","unstructured":"Carey DG. Abdominal obesity. Curr Opin Lipidol. 1998;9(1):35\u201340.","journal-title":"Curr Opin Lipidol"},{"issue":"8","key":"2344_CR36","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00125-007-0708-y","volume":"50","author":"T McLaughlin","year":"2007","unstructured":"McLaughlin T, Sherman A, Tsao P, Gonzalez O, Yee G, Lamendola C, et al. Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia. 2007;50(8):1707\u201315.","journal-title":"Diabetologia"},{"issue":"9","key":"2344_CR37","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.1210\/jcem.86.9.7814","volume":"86","author":"AP Goldstone","year":"2001","unstructured":"Goldstone AP, Thomas EL, Brynes AE, Bell JD, Frost G, Saeed N, et al. Visceral adipose tissue and metabolic complications of obesity are reduced in Prader\u2013Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab. 2001;86(9):4330\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2344_CR38","doi-asserted-by":"publisher","first-page":"E1727","DOI":"10.1210\/jc.2014-2059","volume":"99","author":"NC Olarescu","year":"2014","unstructured":"Olarescu NC, Jorgensen AP, Godang K, Jurik AG, Froslie KF, Bollerslev J. Dual-energy X-ray absorptiometry is a valid method to estimatimate visceral adipose tissue in adult patients with Prader\u2013Willi syndrome during treatment with growth hormone. J Clin Endocrinol Metab. 2014;99(9):E1727\u201331.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11\u201312","key":"2344_CR39","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1055\/s-2002-38256","volume":"34","author":"BL Wajchenberg","year":"2002","unstructured":"Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res. 2002;34(11\u201312):616\u201321.","journal-title":"Horm Metab Res"},{"issue":"4","key":"2344_CR40","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/sj.ijo.0800400","volume":"21","author":"SJ Marks","year":"1997","unstructured":"Marks SJ, Moore NR, Ryley NG, Clark ML, Pointon JJ, Strauss BJ, et al. Measurement of liver fat by MRI and its reduction by dexfenfluramine in NIDDM. Int J Obes Relat Metab Disord. 1997;21(4):274\u20139.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"8","key":"2344_CR41","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7150\/ijbs.8672","volume":"10","author":"S Mori","year":"2014","unstructured":"Mori S, Kiuchi S, Ouchi A, Hase T, Murase T. Characteristic expression of extracellular matrix in subcutaneous adipose tissue development and adipogenesis; comparison with visceral adipose tissue. Int J Biol Sci. 2014;10(8):825\u201333.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"2344_CR42","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/1573399810602040367","volume":"2","author":"O Hamdy","year":"2006","unstructured":"Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev. 2006;2(4):367\u201373.","journal-title":"Curr Diabetes Rev"},{"issue":"12","key":"2344_CR43","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.2337\/diab.45.12.1684","volume":"45","author":"N Abate","year":"1996","unstructured":"Abate N, Garg A, Peshock RM, Stray-Gundersen J, Adams-Huet B, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes. 1996;45(12):1684\u201393.","journal-title":"Diabetes"},{"issue":"1","key":"2344_CR44","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1172\/JCI118083","volume":"96","author":"N Abate","year":"1995","unstructured":"Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest. 1995;96(1):88\u201398.","journal-title":"J Clin Invest"},{"issue":"8","key":"2344_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000812","volume":"2","author":"M Chandalia","year":"2007","unstructured":"Chandalia M, Lin P, Seenivasan T, Livingston EH, Snell PG, Grundy SM, et al. Insulin resistance and body fat distribution in South Asian men compared to Caucasian men. PLoS ONE. 2007;2(8): e812.","journal-title":"PLoS ONE"},{"issue":"10","key":"2344_CR46","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1210\/jc.2009-0980","volume":"94","author":"L Frederiksen","year":"2009","unstructured":"Frederiksen L, Nielsen TL, Wraae K, Hagen C, Frystyk J, Flyvbjerg A, et al. Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men. J Clin Endocrinol Metab. 2009;94(10):4010\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2344_CR47","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.2337\/diacare.26.11.3148","volume":"26","author":"S Shadid","year":"2003","unstructured":"Shadid S, Jensen MD. Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity. Diabetes Care. 2003;26(11):3148\u201352.","journal-title":"Diabetes Care"},{"issue":"2","key":"2344_CR48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00125-004-1637-7","volume":"48","author":"MB Snijder","year":"2005","unstructured":"Snijder MB, Visser M, Dekker JM, Goodpaster BH, Harris TB, Kritchevsky SB, et al. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The health ABC study. Diabetologia. 2005;48(2):301\u20138.","journal-title":"Diabetologia"},{"issue":"2","key":"2344_CR49","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2337\/diacare.27.2.372","volume":"27","author":"MB Snijder","year":"2004","unstructured":"Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CDA, Yudkin JS, et al. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. Diabetes Care. 2004;27(2):372\u20137.","journal-title":"Diabetes Care"},{"issue":"1","key":"2344_CR50","first-page":"39","volume":"65","author":"A Caix\u00e0s","year":"2006","unstructured":"Caix\u00e0s A, Gim\u00e9nez-Palop O, Gim\u00e9nez-P\u00e9rez G, Potau N, Berlanga E, Gonz\u00e1lez-Glemente J-M, et al. Postprandial adiponectin levels are unlikely to contribute to the pathogenesis of obesity in Prader\u2013Willi syndrome. Horm Res. 2006;65(1):39\u201345.","journal-title":"Horm Res"},{"issue":"4","key":"2344_CR51","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1530\/eje.0.1510457","volume":"151","author":"C Hoybye","year":"2004","unstructured":"Hoybye C, Bruun JM, Richelsen B, Flyvbjerg A, Frystyk J. Serum adiponectin levels in adults with Prader\u2013Willi syndrome are independent of anthropometrical parameters and do not change with GH treatment. Eur J Endocrinol. 2004;151(4):457\u201361.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2344_CR52","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/sj.ijo.0803115","volume":"30","author":"L Kennedy","year":"2006","unstructured":"Kennedy L, Bittel DC, Kibiryeva N, Kalra SP, Torto R, Butler MG. Circulating adiponectin levels, body composition and obesity-related variables in Prader\u2013Willi syndrome: comparison with obese subjects. Int J Obes (Lond). 2006;30(2):382\u20137.","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"2344_CR53","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1210\/en.2010-0709","volume":"152","author":"AA Tennese","year":"2011","unstructured":"Tennese AA, Wevrick R. Impaired hypothalamic regulation of endocrine function and delayed counterregulatory response to hypoglycemia in Magel2-null mice. Endocrinology. 2011;152(3):967\u201378.","journal-title":"Endocrinology"},{"issue":"8","key":"2344_CR54","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/90992","volume":"7","author":"AH Berg","year":"2001","unstructured":"Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7(8):947\u201353.","journal-title":"Nat Med"},{"issue":"8","key":"2344_CR55","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/90984","volume":"7","author":"T Yamauchi","year":"2001","unstructured":"Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7(8):941\u20136.","journal-title":"Nat Med"},{"issue":"9","key":"2344_CR56","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1172\/JCI31021","volume":"117","author":"J-Y Kim","year":"2007","unstructured":"Kim J-Y, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest. 2007;117(9):2621\u201337.","journal-title":"J Clin Invest"},{"issue":"4","key":"2344_CR57","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1074\/jbc.M209033200","volume":"278","author":"T Yamauchi","year":"2003","unstructured":"Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, et al. Globular adiponectin protected ob\/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem. 2003;278(4):2461\u20138.","journal-title":"J Biol Chem"},{"issue":"Suppl 7","key":"2344_CR58","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1038\/ijo.2008.233","volume":"32","author":"T Yamauchi","year":"2008","unstructured":"Yamauchi T, Kadowaki T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes (Lond). 2008;32(Suppl 7):S13-18.","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"2344_CR59","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.2337\/diabetes.51.6.1884","volume":"51","author":"N Stefan","year":"2002","unstructured":"Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes. 2002;51(6):1884\u20138.","journal-title":"Diabetes"},{"issue":"4","key":"2344_CR60","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.2337\/db12-0935","volume":"62","author":"H Gao","year":"2013","unstructured":"Gao H, Fall T, van Dam RM, Flyvbjerg A, Zethelius B, Ingelsson E, et al. Evidence of a causal relationship between adiponectin levels and insulin sensitivity: a Mendelian randomization study. Diabetes. 2013;62(4):1338\u201344.","journal-title":"Diabetes"},{"issue":"4","key":"2344_CR61","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1210\/jc.2006-2241","volume":"92","author":"DAM Festen","year":"2007","unstructured":"Festen DAM, van Toorenenbergen A, Duivenvoorden HJ, Hokken-Koelega ACS. Adiponectin levels in prepubertal children with Prader\u2013Willi syndrome before and during growth hormone therapy. J Clin Endocrinol Metab. 2007;92(4):1549\u201354.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11\u201312","key":"2344_CR62","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1055\/s-2002-38246","volume":"34","author":"FM Fisher","year":"2002","unstructured":"Fisher FM, McTernan PG, Valsamakis G, Chetty R, Harte AL, Anwar AJ, et al. Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status. Horm Metab Res. 2002;34(11\u201312):650\u20134.","journal-title":"Horm Metab Res"},{"issue":"3","key":"2344_CR63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.molmet.2013.04.001","volume":"2","author":"R Ye","year":"2013","unstructured":"Ye R, Scherer PE. Adiponectin, driver or passenger on the road to insulin sensitivity? Mol Metab. 2013;2(3):133\u201341.","journal-title":"Mol Metab"},{"issue":"3","key":"2344_CR64","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ymgme.2014.09.003","volume":"113","author":"C Caselli","year":"2014","unstructured":"Caselli C. Role of adiponectin system in insulin resistance. Mol Genet Metab. 2014;113(3):155\u201360.","journal-title":"Mol Genet Metab"},{"issue":"11","key":"2344_CR65","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrm3198","volume":"12","author":"AG Cristancho","year":"2011","unstructured":"Cristancho AG, Lazar MA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol. 2011;12(11):722\u201334.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"2344_CR66","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","volume":"86","author":"C Weyer","year":"2001","unstructured":"Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86(5):1930\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2344_CR67","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","volume":"20","author":"K Hotta","year":"2000","unstructured":"Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20(6):1595\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2344_CR68","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2337\/diacare.27.2.547","volume":"27","author":"F Bacha","year":"2004","unstructured":"Bacha F, Saad R, Gungor N, Arslanian SA. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care. 2004;27(2):547\u201352.","journal-title":"Diabetes Care"},{"issue":"1","key":"2344_CR69","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.advms.2015.10.002","volume":"61","author":"KA Majewska","year":"2016","unstructured":"Majewska KA, Majewski D, Skowro\u0144ska B, Stankiewicz W, Fichna P. Serum leptin and adiponectin levels in children with type 1 diabetes mellitus\u2014relation to body fat mass and disease course. Adv Med Sci. 2016;61(1):117\u201322.","journal-title":"Adv Med Sci"},{"issue":"7","key":"2344_CR70","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nm0702-643","volume":"8","author":"DE Cummings","year":"2002","unstructured":"Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med. 2002;8(7):643\u20134.","journal-title":"Nat Med"},{"issue":"7","key":"2344_CR71","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1210\/jc.2007-2138","volume":"93","author":"E Feigerlova","year":"2008","unstructured":"Feigerlova E, Diene G, Conte-Auriol F, Molinas C, Gennero I, Salles J-P, et al. Hyperghrelinemia precedes obesity in Prader\u2013Willi syndrome. J Clin Endocrinol Metab. 2008;93(7):2800\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2344_CR72","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12728","volume":"31","author":"M Tauber","year":"2019","unstructured":"Tauber M, Coupaye M, Diene G, Molinas C, Valette M, Beauloye V. Prader\u2013Willi syndrome: a model for understanding the ghrelin system. J Neuroendocrinol. 2019;31(7): e12728.","journal-title":"J Neuroendocrinol"},{"issue":"6","key":"2344_CR73","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1365-2265.2008.03385.x","volume":"69","author":"AM Haqq","year":"2008","unstructured":"Haqq AM, Grambow SC, Muehlbauer M, Newgard CB, Svetkey LP, Carrel AL, et al. Ghrelin concentrations in Prader\u2013Willi syndrome (PWS) infants and children: changes during development. Clin Endocrinol. 2008;69(6):911\u201320.","journal-title":"Clin Endocrinol"},{"issue":"1","key":"2344_CR74","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ajmg.a.36810","volume":"167A","author":"FA Kweh","year":"2015","unstructured":"Kweh FA, Miller JL, Sulsona CR, Wasserfall C, Atkinson M, Shuster JJ, et al. Hyperghrelinemia in Prader\u2013Willi syndrome begins in early infancy long before the onset of hyperphagia. Am J Med Genet A. 2015;167A(1):69\u201379.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"2344_CR75","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jpeds.2006.04.011","volume":"149","author":"CR Erdie-Lalena","year":"2006","unstructured":"Erdie-Lalena CR, Holm VA, Kelly PC, Frayo RS, Cummings DE. Ghrelin levels in young children with Prader\u2013Willi syndrome. J Pediatr. 2006;149(2):199\u2013204.","journal-title":"J Pediatr"},{"issue":"3","key":"2344_CR76","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s12020-015-0614-x","volume":"50","author":"RJ Kuppens","year":"2015","unstructured":"Kuppens RJ, Diene G, Bakker NE, Molinas C, Faye S, Nicolino M, et al. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader\u2013Willi syndrome. Endocrine. 2015;50(3):633\u201342.","journal-title":"Endocrine"},{"key":"2344_CR77","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13023-016-0440-0","volume":"11","author":"V Beauloye","year":"2016","unstructured":"Beauloye V, Diene G, Kuppens R, Zech F, Winandy C, Molinas C, et al. High unacylated ghrelin levels support the concept of anorexia in infants with Prader\u2013Willi syndrome. Orphanet J Rare Dis. 2016;11:56.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2344_CR78","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1210\/jc.2003-031118","volume":"89","author":"AP Goldstone","year":"2004","unstructured":"Goldstone AP, Thomas EL, Brynes AE, Castroman G, Edwards R, Ghatei MA, et al. Elevated fasting plasma ghrelin in Prader\u2013Willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance. J Clin Endocrinol Metab. 2004;89(4):1718\u201326.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2344_CR79","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.clnu.2008.12.002","volume":"28","author":"F Prodam","year":"2009","unstructured":"Prodam F, Bellone S, Grugni G, Crino A, Ragusa L, Franzese A, et al. Influence of age, gender, and glucose tolerance on fasting and fed acylated ghrelin in Prader Willi syndrome. Clin Nutr. 2009;28(1):94\u20139.","journal-title":"Clin Nutr"},{"issue":"5","key":"2344_CR80","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1210\/jc.2005-2168","volume":"91","author":"KH Paik","year":"2006","unstructured":"Paik KH, Choe YH, Park WH, Oh YJ, Kim AH, Chu SH, et al. Suppression of acylated ghrelin during oral glucose tolerance test is correlated with whole-body insulin sensitivity in children with Prader\u2013Willi syndrome. J Clin Endocrinol Metab. 2006;91(5):1876\u201381.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2344_CR81","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1210\/jc.2006-0754","volume":"92","author":"WH Park","year":"2007","unstructured":"Park WH, Oh YJ, Kim GY, Kim SE, Paik K-H, Han SJ, et al. Obestatin is not elevated or correlated with insulin in children with Prader\u2013Willi syndrome. J Clin Endocrinol Metab. 2007;92(1):229\u201334.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2344_CR82","doi-asserted-by":"publisher","first-page":"328","DOI":"10.4239\/wjd.v5.i3.328","volume":"5","author":"F Chabot","year":"2014","unstructured":"Chabot F, Caron A, Laplante M, St-Pierre DH. Interrelationships between ghrelin, insulin and glucose homeostasis: physiological relevance. World J Diabetes. 2014;5(3):328\u201341.","journal-title":"World J Diabetes"},{"issue":"4","key":"2344_CR83","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1210\/jc.2003-031572","volume":"89","author":"T McLaughlin","year":"2004","unstructured":"McLaughlin T, Abbasi F, Lamendola C, Frayo RS, Cummings DE. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J Clin Endocrinol Metab. 2004;89(4):1630\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2344_CR84","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.1210\/jcem.86.10.8098","volume":"86","author":"F Broglio","year":"2001","unstructured":"Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti M, et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab. 2001;86(10):5083\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"2344_CR85","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.peptides.2017.12.015","volume":"100","author":"A-L Poher","year":"2018","unstructured":"Poher A-L, Tschoep MH, Mueller TD. Ghrelin regulation of glucose metabolism. Peptides. 2018;100:236\u201342.","journal-title":"Peptides"},{"issue":"12","key":"2344_CR86","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.2337\/diabetes.53.12.3142","volume":"53","author":"K Dezaki","year":"2004","unstructured":"Dezaki K, Hosoda H, Kakei M, Hashiguchi S, Watanabe M, Kangawa K, et al. Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta-cells: implication in the glycemic control in rodents. Diabetes. 2004;53(12):3142\u201351.","journal-title":"Diabetes"},{"issue":"1\u20133","key":"2344_CR87","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.regpep.2008.03.011","volume":"150","author":"KA Longo","year":"2008","unstructured":"Longo KA, Charoenthongtrakul S, Giuliana DJ, Govek EK, McDonagh T, Qi Y, et al. Improved insulin sensitivity and metabolic flexibility in ghrelin receptor knockout mice. Regul Pept. 2008;150(1\u20133):55\u201361.","journal-title":"Regul Pept"},{"issue":"5","key":"2344_CR88","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cmet.2006.04.004","volume":"3","author":"Y Sun","year":"2006","unstructured":"Sun Y, Asnicar M, Saha PK, Chan L, Smith RG. Ablation of ghrelin improves the diabetic but not obese phenotype of ob\/ob mice. Cell Metab. 2006;3(5):379\u201386.","journal-title":"Cell Metab"},{"issue":"1","key":"2344_CR89","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1385\/ENDO:22:1:19","volume":"22","author":"F Broglio","year":"2003","unstructured":"Broglio F, Gottero C, Benso A, Prodam F, Volante M, Destefanis S, et al. Ghrelin and the endocrine pancreas. Endocrine. 2003;22(1):19\u201324.","journal-title":"Endocrine"},{"issue":"1\u20133","key":"2344_CR90","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.regpep.2007.09.017","volume":"146","author":"SS Qader","year":"2008","unstructured":"Qader SS, H\u00e5kanson R, Rehfeld JF, Lundquist I, Salehi A. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas. Regul Pept. 2008;146(1\u20133):230\u20137.","journal-title":"Regul Pept"},{"issue":"10","key":"2344_CR91","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1210\/jc.2004-0363","volume":"89","author":"C Gauna","year":"2004","unstructured":"Gauna C, Meyler FM, Janssen JAMJL, Delhanty PJD, Abribat T, van Koetsveld P, et al. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J Clin Endocrinol Metab. 2004;89(10):5035\u201342.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2344_CR92","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.2337\/db10-0504","volume":"59","author":"J Tong","year":"2010","unstructured":"Tong J, Prigeon RL, Davis HW, Bidlingmaier M, Kahn SE, Cummings DE, et al. Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans. Diabetes. 2010;59(9):2145\u201351.","journal-title":"Diabetes"},{"issue":"7","key":"2344_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011749","volume":"5","author":"PJD Delhanty","year":"2010","unstructured":"Delhanty PJD, Sun Y, Visser JA, van Kerkwijk A, Huisman M, van Ijcken WFJ, et al. Unacylated ghrelin rapidly modulates lipogenic and insulin signaling pathway gene expression in metabolically active tissues of GHSR deleted mice. PLoS ONE. 2010;5(7): e11749.","journal-title":"PLoS ONE"},{"issue":"5","key":"2344_CR94","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1530\/EJE-11-0982","volume":"166","author":"A Benso","year":"2012","unstructured":"Benso A, St-Pierre DH, Prodam F, Gramaglia E, Granata R, van der Lely AJ, et al. Metabolic effects of overnight continuous infusion of unacylated ghrelin in humans. Eur J Endocrinol. 2012;166(5):911\u20136.","journal-title":"Eur J Endocrinol"},{"key":"2344_CR95","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000346059","volume-title":"Ghrelin system","author":"PJ Delhanty","year":"2013","unstructured":"Delhanty PJ, Neggers SJ, van der Ley AJ. Des-acyl ghrelin: a metabolically active peptide. In: Benso A, Casanueva FF, Ghigo E, Granata R, editors. Ghrelin system. Karger Publishers; 2013. p. 112\u201321."},{"issue":"6","key":"2344_CR96","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1530\/EJE-13-0347","volume":"170","author":"B Ozcan","year":"2014","unstructured":"Ozcan B, Neggers SJCMM, Miller AR, Yang H-C, Lucaites V, Abribat T, et al. Does des-acyl ghrelin improve glycemic control in obese diabetic subjects by decreasing acylated ghrelin levels? Eur J Endocrinol. 2014;170(6):799\u2013807.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2344_CR97","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1530\/EJE-12-0456","volume":"167","author":"PJD Delhanty","year":"2012","unstructured":"Delhanty PJD, Neggers SJ, van der Lely AJ. Mechanisms in endocrinology: Ghrelin: the differences between acyl- and des-acyl ghrelin. Eur J Endocrinol. 2012;167(5):601\u20138.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2344_CR98","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1210\/en.2006-0266","volume":"148","author":"R Granata","year":"2007","unstructured":"Granata R, Settanni F, Biancone L, Trovato L, Nano R, Bertuzzi F, et al. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3\u2032,5\u2032-cyclic adenosine monophosphate\/protein kinase A, extracellular signal-regulated kinase 1\/2, and phosphatidyl inositol 3-Kinase\/Akt signaling. Endocrinology. 2007;148(2):512\u201329.","journal-title":"Endocrinology"},{"issue":"12","key":"2344_CR99","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.1210\/jc.2002-020871","volume":"87","author":"A DelParigi","year":"2002","unstructured":"DelParigi A, Tsch\u00f6p M, Heiman ML, Salbe AD, Vozarova B, Sell SM, et al. High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader\u2013Willi syndrome. J Clin Endocrinol Metab. 2002;87(12):5461\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2344_CR100","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1210\/jc.2003-032137","volume":"89","author":"KH Paik","year":"2004","unstructured":"Paik KH, Jin D-K, Song SY, Lee JE, Ko SH, Song SM, et al. Correlation between fasting plasma ghrelin levels and age, body mass index (BMI), BMI percentiles, and 24-hour plasma ghrelin profiles in Prader\u2013Willi syndrome. J Clin Endocrinol Metab. 2004;89(8):3885\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2344_CR101","first-page":"573","volume":"80","author":"DF Swaab","year":"1995","unstructured":"Swaab DF, Purba JS, Hofman MA. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader\u2013Willi syndrome: a study of five cases. J Clin Endocrinol Metab. 1995;80(2):573\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"20","key":"2344_CR102","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1093\/hmg\/9.20.3101","volume":"9","author":"F Muscatelli","year":"2000","unstructured":"Muscatelli F, Abrous DN, Massacrier A, Boccaccio I, Le Moal M, Cau P, et al. Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader\u2013Willi syndrome. Hum Mol Genet. 2000;9(20):3101\u201310.","journal-title":"Hum Mol Genet"},{"issue":"24","key":"2344_CR103","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1093\/hmg\/ddq424","volume":"19","author":"F Schaller","year":"2010","unstructured":"Schaller F, Watrin F, Sturny R, Massacrier A, Szepetowski P, Muscatelli F. A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene. Hum Mol Genet. 2010;19(24):4895\u2013905.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2344_CR104","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.biopsych.2014.11.010","volume":"78","author":"H Meziane","year":"2015","unstructured":"Meziane H, Schaller F, Bauer S, Villard C, Matarazzo V, Riet F, et al. An early postnatal oxytocin treatment prevents social and learning deficits in adult mice deficient for Magel2, a gene involved in Prader\u2013Willi syndrome and autism. Biol Psychiatry. 2015;78(2):85\u201394.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"2344_CR105","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/ajmg.a.37488","volume":"170","author":"L Johnson","year":"2016","unstructured":"Johnson L, Manzardo AM, Miller JL, Driscoll DJ, Butler MG. Elevated plasma oxytocin levels in children with Prader\u2013Willi syndrome compared with healthy unrelated siblings. Am J Med Genet A. 2016;170(3):594\u2013601.","journal-title":"Am J Med Genet A"},{"issue":"12","key":"2344_CR106","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/S0006-3223(98)00190-5","volume":"44","author":"A Martin","year":"1998","unstructured":"Martin A, State M, Anderson GM, Kaye WM, Hanchett JM, McConaha CW, et al. Cerebrospinal fluid levels of oxytocin in Prader\u2013Willi syndrome: a preliminary report. Biol Psychiatry. 1998;44(12):1349\u201352.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"2344_CR107","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/ajmg.a.31606","volume":"143A","author":"DC Bittel","year":"2007","unstructured":"Bittel DC, Kibiryeva N, Sell SM, Strong TV, Butler MG. Whole genome microarray analysis of gene expression in Prader\u2013Willi syndrome. Am J Med Genet A. 2007;143A(5):430\u201342.","journal-title":"Am J Med Genet A"},{"issue":"12","key":"2344_CR108","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrendo.2017.115","volume":"13","author":"EA Lawson","year":"2017","unstructured":"Lawson EA. The effects of oxytocin on eating behaviour and metabolism in humans. Nat Rev Endocrinol. 2017;13(12):700\u20139.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2344_CR109","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/obr.12757","volume":"20","author":"C Ding","year":"2019","unstructured":"Ding C, Leow MK-S, Magkos F. Oxytocin in metabolic homeostasis: implications for obesity and diabetes management. Obes Rev. 2019;20(1):22\u201340.","journal-title":"Obes Rev"},{"issue":"3","key":"2344_CR110","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s13679-019-00355-z","volume":"8","author":"C Ding","year":"2019","unstructured":"Ding C, Magkos F. Oxytocin and vasopressin systems in obesity and metabolic health: mechanisms and perspectives. Curr Obes Rep. 2019;8(3):301\u201316.","journal-title":"Curr Obes Rep"},{"issue":"2","key":"2344_CR111","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1210\/endrev\/bnz012","volume":"41","author":"SE McCormack","year":"2020","unstructured":"McCormack SE, Blevins JE, Lawson EA. Metabolic effects of oxytocin. Endocr Rev. 2020;41(2):121\u201345.","journal-title":"Endocr Rev"},{"issue":"2","key":"2344_CR112","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1152\/physrev.2001.81.2.629","volume":"81","author":"G Gimpl","year":"2001","unstructured":"Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev. 2001;81(2):629\u201383.","journal-title":"Physiol Rev"},{"key":"2344_CR113","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.peptides.2017.12.019","volume":"100","author":"S Mohan","year":"2018","unstructured":"Mohan S, Khan D, Moffett RC, Irwin N, Flatt PR. Oxytocin is present in islets and plays a role in beta-cell function and survival. Peptides. 2018;100:260\u20138.","journal-title":"Peptides"},{"issue":"2","key":"2344_CR114","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4149\/endo_2014_02_87","volume":"48","author":"SK Elabd","year":"2014","unstructured":"Elabd SK, Sabry I, Mohasseb M, Algendy A. Oxytocin as a novel therapeutic option for type I diabetes and diabetic osteopathy. Endocr Regul. 2014;48(2):87\u2013102.","journal-title":"Endocr Regul"},{"issue":"1","key":"2344_CR115","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41598-020-57855-5","volume":"10","author":"S Mai","year":"2020","unstructured":"Mai S, Grugni G, Mele C, Vietti R, Vigna L, Sartorio A, et al. Irisin levels in genetic and essential obesity: clues for a potential dual role. Sci Rep. 2020;10(1):1020.","journal-title":"Sci Rep"},{"issue":"7382","key":"2344_CR116","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature10777","volume":"481","author":"P Bostr\u00f6m","year":"2012","unstructured":"Bostr\u00f6m P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463\u20138.","journal-title":"Nature"},{"issue":"4","key":"2344_CR117","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.metabol.2013.12.007","volume":"63","author":"AB Crujeiras","year":"2014","unstructured":"Crujeiras AB, Zulet MA, Lopez-Legarrea P, de la Iglesia R, Pardo M, Carreira MC, et al. Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients. Metabolism. 2014;63(4):520\u201331.","journal-title":"Metabolism"},{"issue":"6","key":"2344_CR118","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.metabol.2016.02.006","volume":"65","author":"S Qiu","year":"2016","unstructured":"Qiu S, Cai X, Yin H, Z\u00fcgel M, Sun Z, Steinacker JM, et al. Association between circulating irisin and insulin resistance in non-diabetic adults: a meta-analysis. Metabolism. 2016;65(6):825\u201334.","journal-title":"Metabolism"},{"key":"2344_CR119","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s12020-021-02875-y","volume":"75","author":"S Zheng","year":"2021","unstructured":"Zheng S, Chen N, Kang X, Hu Y, Shi S. Irisin alleviates FFA induced \u03b2-cell insulin resistance and inflammatory response through activating PI3K\/AKT\/FOXO1 signaling pathway. Endocrine. 2021;75:740\u201351.","journal-title":"Endocrine"},{"issue":"4","key":"2344_CR120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060563","volume":"8","author":"A Roca-Rivada","year":"2013","unstructured":"Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Bel\u00e9n Crujeiras A, et al. FNDC5\/irisin is not only a myokine but also an adipokine. PLoS ONE. 2013;8(4): e60563.","journal-title":"PLoS ONE"},{"issue":"3","key":"2344_CR121","doi-asserted-by":"publisher","first-page":"E405","DOI":"10.1152\/ajpendo.00423.2003","volume":"287","author":"J-L Liu","year":"2004","unstructured":"Liu J-L, Coschigano KT, Robertson K, Lipsett M, Guo Y, Kopchick JJ, et al. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am J Physiol Endocrinol Metab. 2004;287(3):E405-413.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"2344_CR122","doi-asserted-by":"publisher","first-page":"E909","DOI":"10.1152\/ajpendo.00185.2010","volume":"300","author":"M Stefan","year":"2011","unstructured":"Stefan M, Simmons RA, Bertera S, Trucco M, Esni F, Drain P, et al. Global deficits in development, function, and gene expression in the endocrine pancreas in a deletion mouse model of Prader\u2013Willi syndrome. Am J Physiol Endocrinol Metab. 2011;300(5):E909-922.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2344_CR123","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fendo.2018.00321","volume":"9","author":"A Ciresi","year":"2018","unstructured":"Ciresi A, Giordano C. Glucose metabolism in children with growth hormone deficiency. Front Endocrinol (Lausanne). 2018;9:321.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2344_CR124","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1210\/jc.2011-2590","volume":"97","author":"CRP Oliveira","year":"2012","unstructured":"Oliveira CRP, Salvatori R, Barreto-Filho JAS, Rocha IES, Mari A, Pereira RMC, et al. Insulin sensitivity and \u03b2-cell function in adults with lifetime, untreated isolated growth hormone deficiency. J Clin Endocrinol Metab. 2012;97(3):1013\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2344_CR125","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1530\/EC-13-0014","volume":"2","author":"TAR Vicente","year":"2013","unstructured":"Vicente TAR, Rocha IES, Salvatori R, Oliveira CRP, Pereira RMC, Souza AHO, et al. Lifetime congenital isolated GH deficiency does not protect from the development of diabetes. Endocr Connect. 2013;2(2):112\u20137.","journal-title":"Endocr Connect"},{"issue":"7","key":"2344_CR126","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1210\/jc.2015-1678","volume":"100","author":"J Guevara-Aguirre","year":"2015","unstructured":"Guevara-Aguirre J, Rosenbloom AL, Balasubramanian P, Teran E, Guevara-Aguirre M, Guevara C, et al. GH receptor deficiency in ecuadorian adults is associated with obesity and enhanced insulin sensitivity. J Clin Endocrinol Metab. 2015;100(7):2589\u201396.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2344_CR127","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11154-020-09601-5","volume":"22","author":"EO List","year":"2021","unstructured":"List EO, Basu R, Duran-Ortiz S, Krejsa J, Jensen EA. Mouse models of growth hormone deficiency. Rev Endocr Metab Disord. 2021;22(1):3\u201316.","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"2344_CR128","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ghir.2004.02.005","volume":"14","author":"DE Berryman","year":"2004","unstructured":"Berryman DE, List EO, Coschigano KT, Behar K, Kim JK, Kopchick JJ. Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm IGF Res. 2004;14(4):309\u201318.","journal-title":"Growth Horm IGF Res"},{"issue":"6","key":"2344_CR129","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1172\/JCI45027","volume":"121","author":"Y Wu","year":"2011","unstructured":"Wu Y, Liu C, Sun H, Vijayakumar A, Giglou PR, Qiao R, et al. Growth hormone receptor regulates \u03b2 cell hyperplasia and glucose-stimulated insulin secretion in obese mice. J Clin Invest. 2011;121(6):2422\u20136.","journal-title":"J Clin Invest"},{"issue":"1","key":"2344_CR130","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1365-2265.2011.04303.x","volume":"77","author":"R Sanchez-Ortiga","year":"2012","unstructured":"Sanchez-Ortiga R, Klibanski A, Tritos NA. Effects of recombinant human growth hormone therapy in adults with Prader\u2013Willi syndrome: a meta-analysis. Clin Endocrinol. 2012;77(1):86\u201393.","journal-title":"Clin Endocrinol"},{"issue":"10","key":"2344_CR131","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1007\/s00125-020-05204-6","volume":"63","author":"CL Faber","year":"2020","unstructured":"Faber CL, Deem JD, Campos CA, Taborsky GJ, Morton GJ. CNS control of the endocrine pancreas. Diabetologia. 2020;63(10):2086\u201394.","journal-title":"Diabetologia"},{"issue":"1","key":"2344_CR132","doi-asserted-by":"publisher","first-page":"E225","DOI":"10.1210\/jc.2010-1733","volume":"96","author":"AM Haqq","year":"2011","unstructured":"Haqq AM, Muehlbauer MJ, Newgard CB, Grambow S, Freemark M. The metabolic phenotype of Prader\u2013Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. J Clin Endocrinol Metab. 2011;96(1):E225\u201332.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2344_CR133","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1002\/dvdy.21615","volume":"237","author":"AA Tennese","year":"2008","unstructured":"Tennese AA, Gee CB, Wevrick R. Loss of the Prader\u2013Willi syndrome protein necdin causes defective migration, axonal outgrowth, and survival of embryonic sympathetic neurons. Dev Dyn. 2008;237(7):1935\u201343.","journal-title":"Dev Dyn"},{"issue":"1","key":"2344_CR134","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1542\/peds.93.1.76","volume":"93","author":"FJ DiMario","year":"1994","unstructured":"DiMario FJ, Dunham B, Burleson JA, Moskovitz J, Cassidy SB. An evaluation of autonomic nervous system function in patients with Prader\u2013Willi syndrome. Pediatrics. 1994;93(1):76\u201381.","journal-title":"Pediatrics"},{"issue":"6","key":"2344_CR135","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1210\/jc.2004-1651","volume":"90","author":"YH Choe","year":"2005","unstructured":"Choe YH, Jin D-K, Kim SE, Song SY, Paik KH, Park HY, et al. Hyperghrelinemia does not accelerate gastric emptying in Prader\u2013Willi syndrome patients. J Clin Endocrinol Metab. 2005;90(6):3367\u201370.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2344_CR136","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1172\/JCI0215736","volume":"110","author":"F Kreier","year":"2002","unstructured":"Kreier F, Fliers E, Voshol PJ, Van Eden CG, Havekes LM, Kalsbeek A, et al. Selective parasympathetic innervation of subcutaneous and intra-abdominal fat\u2013functional implications. J Clin Invest. 2002;110(9):1243\u201350.","journal-title":"J Clin Invest"},{"issue":"4","key":"2344_CR137","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/oby.2005.81","volume":"13","author":"S Lindmark","year":"2005","unstructured":"Lindmark S, L\u00f6nn L, Wiklund U, Tufvesson M, Olsson T, Eriksson JW. Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance. Obes Res. 2005;13(4):717\u201328.","journal-title":"Obes Res"},{"issue":"7","key":"2344_CR138","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.peptides.2008.02.022","volume":"29","author":"C Cui","year":"2008","unstructured":"Cui C, Ohnuma H, Daimon M, Susa S, Yamaguchi H, Kameda W, et al. Ghrelin infused into the portal vein inhibits glucose-stimulated insulin secretion in Wistar rats. Peptides. 2008;29(7):1241\u20136.","journal-title":"Peptides"},{"issue":"5","key":"2344_CR139","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/oby.2009.12","volume":"17","author":"C Camerino","year":"2009","unstructured":"Camerino C. Low sympathetic tone and obese phenotype in oxytocin-deficient mice. Obesity (Silver Spring). 2009;17(5):980\u20134.","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"2344_CR140","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/nu12041063","volume":"12","author":"S Garcia-Ribera","year":"2020","unstructured":"Garcia-Ribera S, Amat-Bou M, Climent E, Llobet M, Chenoll E, Corripio R, et al. Specific dietary components and gut microbiota composition are associated with obesity in children and adolescents with Prader\u2013Willi syndrome. Nutrients. 2020;12(4):1063.","journal-title":"Nutrients"},{"issue":"7","key":"2344_CR141","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1136\/gutjnl-2019-319322","volume":"69","author":"LM Olsson","year":"2020","unstructured":"Olsson LM, Poitou C, Tremaroli V, Coupaye M, Aron-Wisnewsky J, B\u00e4ckhed F, et al. Gut microbiota of obese subjects with Prader\u2013Willi syndrome is linked to metabolic health. Gut. 2020;69(7):1229\u201338.","journal-title":"Gut"},{"issue":"2","key":"2344_CR142","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1469-8749.1987.tb02129.x","volume":"29","author":"LR Greenswag","year":"1987","unstructured":"Greenswag LR. Adults with Prader\u2013Willi syndrome: a survey of 232 cases. Dev Med Child Neurol. 1987;29(2):145\u201352.","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"2344_CR143","first-page":"279","volume":"53","author":"M Tauber","year":"2000","unstructured":"Tauber M, Barbeau C, Jouret B, Pienkowski C, Malzac P, Moncla A, et al. Auxological and endocrine evolution of 28 children with Prader\u2013Willi syndrome: effect of GH therapy in 14 children. Horm Res. 2000;53(6):279\u201387.","journal-title":"Horm Res"},{"issue":"4","key":"2344_CR144","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1017\/S001216220100202X","volume":"44","author":"JV Butler","year":"2002","unstructured":"Butler JV, Whittington JE, Holland AJ, Boer H, Clarke D, Webb T. Prevalence of, and risk factors for, physical ill-health in people with Prader\u2013Willi syndrome: a population-based study. Dev Med Child Neurol. 2002;44(4):248\u201355.","journal-title":"Dev Med Child Neurol"},{"issue":"Pt 1","key":"2344_CR145","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-2788.2005.00770.x","volume":"50","author":"AK Thomson","year":"2006","unstructured":"Thomson AK, Glasson EJ, Bittles AH. A long-term population-based clinical and morbidity review of Prader\u2013Willi syndrome in Western Australia. J Intellect Disabil Res. 2006;50(Pt 1):69\u201378.","journal-title":"J Intellect Disabil Res"},{"issue":"9","key":"2344_CR146","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1002\/ajmg.a.34171","volume":"155A","author":"M Sinnema","year":"2011","unstructured":"Sinnema M, Maaskant MA, van Schrojenstein Lantman-de Valk HMJ, van Nieuwpoort IC, Drent ML, Curfs LMG, et al. Physical health problems in adults with Prader\u2013Willi syndrome. Am J Med Genet A. 2011;155A(9):2112\u201324.","journal-title":"Am J Med Genet A"},{"issue":"6","key":"2344_CR147","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/ajmg.a.35333","volume":"158A","author":"M Sinnema","year":"2012","unstructured":"Sinnema M, Schrander-Stumpel CTRM, Maaskant MA, Boer H, Curfs LMG. Aging in Prader\u2013Willi syndrome: twelve persons over the age of 50 years. Am J Med Genet A. 2012;158A(6):1326\u201336.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"2344_CR148","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/cen.14274","volume":"93","author":"L Damen","year":"2020","unstructured":"Damen L, Grootjen LN, Donze SH, Juriaans AF, de Graaff LCG, van der Velden JAEM, et al. Three years of growth hormone treatment in young adults with Prader\u2013Willi Syndrome previously treated with growth hormone in childhood: effects on glucose homeostasis and metabolic syndrome. Clin Endocrinol (Oxf). 2020;93(4):439\u201348.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2344_CR149","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/S0026-0495(96)90181-X","volume":"45","author":"DP Schuster","year":"1996","unstructured":"Schuster DP, Osei K, Zipf WB. Characterization of alterations in glucose and insulin metabolism in Prader\u2013Willi subjects. Metabolism. 1996;45(12):1514\u201320.","journal-title":"Metabolism"},{"issue":"2","key":"2344_CR150","first-page":"83","volume":"68","author":"A Crino","year":"2007","unstructured":"Crino A, Di Giorgio G, Manco M, Grugni G, Maggioni A. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader\u2013Willi syndrome. Horm Res. 2007;68(2):83\u201390.","journal-title":"Horm Res"},{"issue":"3","key":"2344_CR151","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1210\/jc.2009-1489","volume":"95","author":"YB Sohn","year":"2010","unstructured":"Sohn YB, Kwak MJ, Kim SJ, Park SW, Kim CH, Kim MY, et al. Correlation of adiponectin receptor expression with cytokines and insulin sensitivity in growth hormone (GH)-treated children with Prader\u2013Willi syndrome and in non-GH-treated obese children. J Clin Endocrinol Metab. 2010;95(3):1371\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2344_CR152","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1038\/oby.2011.349","volume":"20","author":"MF Faienza","year":"2012","unstructured":"Faienza MF, Ventura A, Lauciello R, Crino A, Ragusa L, Cavallo L, et al. Analysis of endothelial protein c receptor gene and metabolic profile in Prader\u2013Willi syndrome and obese subjects. Obesity. 2012;20(9):1866\u201370.","journal-title":"Obesity"},{"issue":"6","key":"2344_CR153","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/cen.12766","volume":"83","author":"KA Irizarry","year":"2015","unstructured":"Irizarry KA, Bain J, Butler MG, Ilkayeva O, Muehlbauer M, Haqq AM, et al. Metabolic profiling in Prader\u2013Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone. Clin Endocrinol. 2015;83(6):797\u2013805.","journal-title":"Clin Endocrinol"},{"issue":"9","key":"2344_CR154","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.3390\/nu12092583","volume":"12","author":"M Paolo","year":"2020","unstructured":"Paolo M, Chiara M, Alessandro M, Stefania M, Massimo S, Alessandro S, et al. Fat-free mass is better related to serum uric acid than metabolic homeostasis in Prader\u2013Willi syndrome. Nutrients. 2020;12(9):2583.","journal-title":"Nutrients"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02344-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02344-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02344-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T11:26:54Z","timestamp":1651922814000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02344-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,7]]},"references-count":154,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2344"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02344-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,7]]},"assertion":[{"value":"8 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}